Quantitative assessment of oligomeric amyloid β peptide binding to α7 nicotinic receptor
Open Access
- 13 April 2019
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 176 (18) , 3475-3488
Abstract
Background and Purpose: Progressive dysfunction of cholinergic transmission is a well‐known characteristic of Alzheimer's disease (AD). Amyloid β (Aβ) peptide oligomers are known to play a central role in AD and are suggested to impair the function of the cholinergic nicotinic ACh receptor α7 (α7nAChR). However, the mechanism underlying the effect of Aβ on α7nAChR function is not fully understood, limiting the therapeutic exploration of this observation in AD. Here, we aimed to detect and characterize Aβ binding to α7nAChR, including the possibility of interfering with this interaction for therapeutic purposes.Experimental Approach: We developed a specific and quantitative time‐resolved FRET (TR‐FRET)‐based binding assay for Aβ to α7nAChR and pharmacologically characterized this interaction.Key Results: We demonstrated specific and high‐affinity (low nanomolar) binding of Aβ to the orthosteric binding site of α7nAChR. Aβ binding was prevented and reversed by the well‐characterized orthosteric ligands of α7nAChR (epibatidine, α‐bungarotoxin, methylylcaconitine, PNU‐282987, S24795, and EVP6124) and by the type II positive allosteric modulator (PAM) PNU‐120596 but not by the type I PAM NS1738.Conclusions and Implications: Our TR‐FRET Aβ binding assay demonstrates for the first time the specific binding of Aβ to α7nAChR, which will be a crucial tool for the development, testing, and selection of a novel generation of AD drug candidates targeting Aβ/α7nAChR complexes with high specificity and fewer side effects compared to currently approved α7nAChR drugs.Linked Articles: This article is part of a themed section on Therapeutics for Dementia and Alzheimer's Disease: New Directions for Precision Medicine. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.18/issuetocKeywords
Funding Information
- Agence Nationale de la Recherche (ANR‐11‐IDEX‐0005‐01)
- Labex (ANR‐11‐LABX‐0071)
- Centre National de la Recherche Scientifique
- Institut National de la Santé et de la Recherche Médicale
- Association France Alzheimer (1610)
This publication has 61 references indexed in Scilit:
- Mitochondria Express α7 Nicotinic Acetylcholine Receptors to Regulate Ca2+ Accumulation and Cytochrome c Release: Study on Isolated MitochondriaPLOS ONE, 2012
- Competitive binding at a nicotinic receptor transmembrane site of two α7-selective positive allosteric modulators with differing effects on agonist-evoked desensitizationNeuropharmacology, 2011
- α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer’s DiseaseThe Open Medicinal Chemistry Journal, 2010
- HTRF: A Technology Tailored for Drug Discovery - A Review of Theoretical Aspects and Recent ApplicationsCurrent Chemical Genomics, 2009
- Positive Allosteric Modulation of the α7 Nicotinic Acetylcholine Receptor: Ligand Interactions with Distinct Binding Sites and Evidence for a Prominent Role of the M2-M3 SegmentMolecular Pharmacology, 2008
- Potentiation of α7 nicotinic acetylcholine receptors via an allosteric transmembrane siteProceedings of the National Academy of Sciences, 2008
- Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitationNeurobiology of Disease, 2006
- Subtype‐specific actions of β‐amyloid peptides on recombinant human neuronal nicotinic acetylcholine receptors (α7, α4β2, α3β4) expressed in Xenopus laevis oocytesBritish Journal of Pharmacology, 2005
- Molecular docking of four β-amyloid1–42 fragments on the α7 nicotinic receptor: delineating the binding site of the Aβ peptidesBiochemical and Biophysical Research Communications, 2004
- A general method for the covalent labeling of fusion proteins with small molecules in vivoNature Biotechnology, 2002